Midlife Plasma Aβ and Late-Life Risk of Cognitive Impairment: The Atherosclerosis Risk in Communities Study

Plasma-based biomarkers of amyloid beta (Aβ), a neuropathological hallmark of Alzheimer’s disease, show promise in predicting cognitive impairment and mapping onto cerebral amyloidosis, but little is known about how midlife plasma Aβ associates with late-life cognitive outcomes. Midlife plasma varia...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Innov Aging
Главные авторы: Sullivan, Kevin, Blackshear, Chad, Sharrett, A Richey, Gottesman, Rebecca, Knopman, David, Windham, B Gwen, Griswold, Michael, Mosley, Thomas
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Abstracts
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7740202/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igaa057.810
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы